Merit Medical Systems, Inc.  

(Public, NASDAQ:MMSI)   Watch this stock  
Find more results for MMSI
9.96
-0.01 (-0.10%)
Real-time:   9:30AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 9.96 - 9.96
52 week 9.15 - 15.37
Open 9.96
Vol / Avg. 0.00/280,331.00
Mkt cap 423.19M
P/E 29.00
Div/yield     -
EPS 0.34
Shares 42.49M
Beta 0.81
Inst. own 83%
Jul 26, 2013
Q2 2013 Merit Medical Systems Inc. Earnings Release Add to calendar
May 22, 2013
Merit Medical Systems Inc. Annual Shareholder Meeting
May 20, 2013
Merit Medical Systems Inc. at UBS Global Healthcare Conference
Apr 26, 2013
Q1 2013 Merit Medical Systems Inc. Earnings Release
Apr 25, 2013
Q1 2013 Merit Medical Systems Inc. Earnings Conference Call - Webcast
Mar 19, 2013
Merit Medical Systems Inc. at Sidoti Emerging Growth Institutional Investor Forum
Mar 6, 2013
Merit Medical Systems Inc. at Raymond James Institutional Investors Conference
Feb 27, 2013
Merit Medical Systems Inc. at Lazard Medical Technology Snowbird Conference
Feb 26, 2013
Merit Medical Systems Inc. at RBC Capital Markets' Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 0.65% 5.00%
Operating margin 1.69% 6.91%
EBITD margin - 15.82%
Return on average assets 0.38% 3.42%
Return on average equity 0.70% 5.34%
Employees 2,760 -
Carbon Disclosure Rating - -

Address

1600 West Merit Parkway
SOUTH JORDAN, UT 84095
United States - Map
+1-801-2531600 (Phone)
+1-801-2531652 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Merit Medical Systems, Inc. (Merit) designs, develops, manufactures and markets medical devices used in interventional and diagnostic procedures. The Company operates in the cardiology, radiology, pulmonology, thoracic surgery, nephrology, vascular surgery and gastroenterology markets. It operates in two segments: cardiovascular segment, which consists of cardiology and radiology devices that assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes the embolotherapeutic products, and endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. In February 2012, the Company acquired the assets of Ostial Solutions, LLC. In December 2012, the Company acquired Thomas Medical Products, Inc.

Officers and directors

Fred P. Lampropoulos Chairman of the Board, President, Chief Executive Officer
Age: 62
Bio & Compensation  - Reuters
Kent W. Stanger Chief Financial Officer, Secretary, Treasurer, Director
Age: 57
Bio & Compensation  - Reuters
Arlin D. Nelson Chief Operating Officer
Age: 71
Bio & Compensation  - Reuters
Martin R. Stephens Executive Vice President - Marketing and Sales
Age: 58
Bio & Compensation  - Reuters
Rashelle Perry Chief Legal Officer
Age: 46
Bio & Compensation  - Reuters
A. Scott Anderson Independent Director
Age: 65
Bio & Compensation  - Reuters
Rex C. Bean Independent Director
Bio & Compensation  - Reuters
Richard W. Edelman Independent Director
Age: 71
Bio & Compensation  - Reuters
Nolan E. Karras Independent Director
Age: 67
Bio & Compensation  - Reuters
Franklin J. Miller M.D. Independent Director
Age: 71
Bio & Compensation  - Reuters